Alprazolam

8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Xanax, Xannies, Zannies, Bars, Xanbars

Psychoactive Class

Depressant Anxiolytic Sedative Muscle Relaxant GABAergic Anticonvulsant

Chemical Class

Alprazolam is a fast-acting depressant of the triazolobenzodiazepine class.¹² Developed by Jackson Hester Jr. at the Upjohn Company, it was patented in 1971 and approved for medical use in the United States in 1981. It is widely prescribed for the management of anxiety and panic disorders² and remains one of the most commonly prescribed medications in the U.S. Regular or excessive use can lead to physical dependence and addiction.¹

Dosage & Duration

Dosage

Threshold~0.25 mg

Light0.25-0.5 mg

Moderate0.5-1.5 mg

Strong1.5-2 mg

Heavy2+ mg

Bioavailability

84-91%

Duration

Onset20-40 minutes

Come Up60-120 minutes

Peak2-4 hours

Offset2-6 hours

After Effects6-24 hours

Total5-8 hours

Half-life

9-16 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of alprazolam can be broken down into several components which progressively intensify proportional to dosage.

Dizziness Muscle relaxation Physical euphoria Motor control loss Respiratory depression Seizure suppression

Cognitive

The cognitive effects of alprazolam can be broken down into several components which progressively intensify proportional to dosage. The general head space of alprazolam is described by many as one of intense sedation, relaxation, anxiety suppression and decreased inhibition. It contains a large number of typical depressant cognitive effects. Paradoxical reactions to benzodiazepines such as increased seizures (in epileptics), aggression, increased anxiety, violent behavior, loss of impulse control, irritability and suicidal behavior sometimes occur (although they are rare in the general population, with an incidence rate below 1%). These paradoxical effects occur with greater frequency in recreational abusers, individuals with mental disorders, children, and patients on high-dosage regimes.

Amnesia Anxiety suppression Thought deceleration Disinhibition Information processing suppression Euphoria Compulsive redosing

Forked from Subjective Effect Documentation

by Josie KinsSeptember 2015.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

Alprazolam acts as a positive allosteric modulator at GABA-A receptors, binding nonselectively to the benzodiazepine site on the receptor complex.^?2 This enhances the effects of GABA, the brain's primary inhibitory neurotransmitter, by increasing chloride ion conductance through the receptor channel, hyperpolarizing neurons and reducing their excitability. The drug affects receptor complexes containing α1 subunits (associated with sedation and amnesia) and α2 subunits (associated with anxiolysis).² Alprazolam also acts as an agonist at the translocator protein and suppresses hypothalamic-pituitary-adrenal axis activity.³ Compared to some other benzodiazepines, alprazolam administration increases extracellular dopamine concentrations in the striatum.⁴

Pharmacokinetics

Alprazolam is rapidly absorbed orally with high bioavailability² and readily crosses the blood-brain barrier. It is primarily metabolized in the liver via CYP3A4,^? with minor contributions from CYP3A5, CYP3A7, and CYP2C9. Hydroxylation produces at least 29 metabolites, primarily 4-hydroxyalprazolam and α-hydroxyalprazolam,^? though these are present at low concentrations with reduced receptor affinity and contribute minimally to the drug's effects. The majority of the dose is eliminated in the urine, largely as unmetabolized alprazolam.^?

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AlcoholGHB/GBLOpioidsTramadol

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

DiphenhydraminePCP

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

DXMKetamineMXE

TripSit

Tolerance

Full Tolerance

Tolerance to sedative-hypnotic effects can emerge quickly, often after only several days of uninterrupted use. Tolerance to cognitive impairment and sedation appears to develop over 1-3 weeks of daily administration, with some research indicating that impairment on most tests resolves by this timeframe. Receptor studies have demonstrated reduced GABA-A benzodiazepine receptor density after approximately 24 days of regular use at therapeutic doses.

Cross Tolerance

Benzodiazepines (all members of the class)

Baseline Reset

Following cessation, tolerance typically returns to baseline within 7-14 days. However, individuals with prolonged or intensive use patterns may require significantly longer periods for complete tolerance reset, proportional to the duration and intensity of their prior use.

Harm Potential

Addiction & Dependence

Psychological

High

Alprazolam is considered highly psychologically addictive with significant abuse potential.⁵ Its high binding affinity, high potency, and rapid onset increase abuse liability.⁵ Compulsive redosing is commonly reported among users seeking a 'high', which frequently leads to blackout states and impaired judgment.

Physical

Extremely High

Physical dependence develops reliably with regular use, particularly at doses above 4 mg daily or with use exceeding six months.^? Withdrawal is potentially life-threatening and can include tremors, seizures, marked delirium, and in rare cases coma or death.^? Medical supervision and gradual tapering over weeks or months is essential; abrupt discontinuation is extremely dangerous.^?

Toxicity

Central Nervous System

Misuse of alprazolam has been shown to cause cognitive impairment including memory deficits; occasional use at therapeutic doses does not appear to cause lasting neurological damage.⁵

Vascular/Muscular

Injection of oral alprazolam preparations has caused dangerous damage to blood vessels, embolization, and rhabdomyolysis; this risk is specific to injection misuse and does not apply to oral administration.

Respiratory

Respiratory depression can occur at high doses or in overdose, particularly when combined with other depressants; patients with pre-existing respiratory impairment are at increased risk.^?

Psychosis Risk

Hallucinations are rare during alprazolam use. Paradoxical reactions including mania, agitation, and rage occur with an incidence below 1% in the general population but are more frequent in recreational abusers, individuals with mental disorders, children, and patients on high-dose regimens.^?6 Delirium and hallucinations may also occur during withdrawal.⁵

Seizure Risk

Alprazolam itself has anticonvulsant properties during use. However, abrupt discontinuation after regular use carries significant seizure risk that can be life-threatening.^?7 Paradoxical increased seizure activity has been reported in epileptics. Gradual dose tapering over weeks is essential to minimize withdrawal seizure risk.^?

History & Culture

Discovery and Development

Alprazolam was first synthesized in 1971 by J.B. Hester at the Upjohn Company, a pharmaceutical manufacturer that would later become part of Pfizer.⁸ The compound was developed as a triazolobenzodiazepine, featuring a triazole ring fused to the core benzodiazepine…

Legality

International

UN Convention on Psychotropic Substances 1971: Schedule IV.

1961 Convention: not internationally scheduled.

1988 Convention: not internationally scheduled.

By Country

United StatesPrescription onlySchedule IV

21 CFR 1308.14⁶¹

Assigned to Schedule IV of the Controlled Substances Act by the Drug Enforcement Administration.⁶² Received FDA approval on October 16, 1981. Illegal to sell without a license and illegal to possess without a valid prescription.

AustraliaPrescription onlySchedule 8

Therapeutic Goods (Poisons Standard—February 2025) Instrument 2025¹³

Originally classified as Schedule 4 (prescription only), alprazolam was rescheduled to Schedule 8 in January 2014,¹⁴ subjecting it to more rigorous prescribing requirements. Maximum in-house consumption is limited to 5 mg per day.

BelgiumPrescription onlyAnnexe III

Arrêté royal du 6 septembre 2017 réglementant les substances stupéfiantes et psychotropes¹⁷¹⁸

Benzodiazepines including alprazolam are regulated as prescription medications under Belgian pharmaceutical law.

CanadaPrescription onlySchedule IV

Controlled Drugs and Substances Act²¹²²

Controlled under Schedule IV of the Controlled Drugs and Substances Act.²³ Requires a valid prescription for lawful possession.

Czech RepublicPrescription onlySeznam č. 7

Nařízení vlády č. 463/2013 Sb., o seznamech návykových látek²⁶²⁷

Controlled substance under Nařízení vlády č. 463/2013 Sb. Available exclusively with a standard prescription (without blue stripe designation).

FrancePrescription onlyListe I

Arrêté du 7 octobre 1991 fixant la liste des substances vénéneuses à propriétés hypnotiques et/ou anxiolytiques³¹

Classified as a List I substance under French pharmaceutical law. Available only by prescription and illegal to purchase without one.

IrelandPrescription onlySchedule 4

Misuse of Drugs (Amendment) Regulations 2022³³

Classified as a Schedule 4 controlled medicine. Requires a valid prescription for legal possession.

JapanPrescription onlyArticle 4(45)

Cabinet Order Designating Narcotics, Narcotic Raw Plants, Psychotropics, and Narcotics/Psychotropics Precursors³⁵³⁶

Alprazolam and its salts are designated psychotropics by Article 4(45) of the Cabinet Order Designating Narcotics, Narcotic Raw Plants, Psychotropics, and Narcotics/Psychotropics Precursors, made under Appended Table III of the Narcotics and Psychotropics Control Law. Japan’s Ministry of Health, Labour and Welfare identifies alprazolam as a Third Category psychotropic and states that psychotropics require a physician’s prescription for use.

NetherlandsPrescription onlyLijst II

Opiumwet³⁸

Controlled under List 2 of the Opium Law. Available for legitimate medical use with a valid prescription.

PhilippinesPrescription onlySchedule 3

Philippine Schedules of Dangerous Drugs, Annex A⁴⁰⁴¹

Alprazolam is included in the Philippine Schedule 3 list of dangerous drugs. The Dangerous Drugs Board schedule identifies its corresponding international classification as Schedule IV of the 1971 Convention.

PortugalPrescription onlyTable IV

Decree-Law No. 15/93, annexed tables⁴⁴⁴⁵

Alprazolam is listed in the tables annexed to Decree-Law No. 15/93 as a controlled psychotropic substance. INFARMED administers the national controls applicable to substances in Tables I to IV, including their lawful medical handling.

SingaporePrescription onlyFirst Schedule

Health Products (Therapeutic Products) Regulations 2016⁴⁶⁴⁷⁴⁸

Alprazolam is listed as a psychotropic substance in the First Schedule to the Health Products (Therapeutic Products) Regulations 2016, including preparations containing it. Registered Xanax products containing alprazolam are classified in Singapore's National Drug Formulary as prescription-only medicines. Import and export of therapeutic products containing psychotropic substances require the applicable Health Sciences Authority approval.

South KoreaPrescription onlySchedule 6

Enforcement Decree of the Narcotics Control Act⁵⁰⁵¹⁵²

Alprazolam is listed in Schedule 6 to the Enforcement Decree of the Narcotics Control Act as a psychotropic drug under Article 2(3)(d) of the Act. Schedule 6 covers drugs used medically with a lower risk of misuse and dependence than the preceding psychotropic category; the Ministry of Food and Drug Safety registers alprazolam products as both prescription medicines and psychotropic drugs. Possession, use, manufacture, sale, and import or export of narcotics and psychotropic drugs are strictly controlled under the Narcotics Control Act.

SwedenPrescription onlyFörteckning IV

Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika⁵⁵⁵⁶

Regulated as a prescription medication under List IV of the Narcotics Drugs Act (Narkotikastrafflagen) of 1968.

TurkeyGreen PrescriptionCitation needed

Designated as a 'green prescription' medication, indicating stricter prescribing controls. Possession or sale without prescription is illegal.

ArgentinaPrescription onlyLista IV

Resolution 518/1985, Annex I¹¹¹²

Alprazolam is included in Lista IV by Resolution 518/1985 under Argentina's psychotropic-substances framework. The substance is subject to the special-control regime administered under Law No. 19.303.

AustriaPrescription onlyNR

Rezeptpflichtverordnung¹⁵¹⁶

Legal for medical use under the Arzneimittelgesetz (AMG). Possession or sale without a valid prescription is prohibited under the Suchtmittelgesetz (SMG).

BrazilPrescription onlyLista B1

Portaria SVS/MS No. 344/1998¹⁹²⁰

Alprazolam is included in Lista B1 of Portaria SVS/MS No. 344/1998. Dispensing is subject to the Notificação de Receita B requirement for psychotropic substances under special control.

ChinaPrescription onlyCategory II

Catalogue of Medicinal Psychotropic Substances (2025 Edition)²⁴²⁵

Alprazolam is included in China's Catalogue of Medicinal Psychotropic Substances. The 2025 catalogue was jointly issued by the National Medical Products Administration, Ministry of Public Security, and National Health Commission and regulates its medical use as a psychotropic substance.

DenmarkPrescription onlyList E (E003)

Executive Order no. 405 of 26 March 2026 on Euphoriant Substances²⁸²⁹³⁰

Alprazolam INN is listed as E003 in List E of Denmark's Executive Order no. 405 of 26 March 2026 on Euphoriant Substances, in force from 29 March 2026. The Order limits euphoriant substances to medical or scientific purposes and permits receipt and possession only through a lawfully issued prescription or other specified authorised channels.

GermanyPrescription onlyAnlage III

Betäubungsmittelgesetz³²

Controlled under Anlage III of the Betäubungsmittelgesetz (Narcotics Act) since August 1, 1986.³² Requires a narcotic prescription form, except for preparations containing up to 1 mg per dosage unit. Maximum of 50 dosage units may be dispensed together.

ItalyPrescription onlyTabella IV

D.P.R. 9 ottobre 1990, n. 309³⁴

Listed in Tabella 4 under the Testo unico sulla droga (D.P.R. 309/90). For medical prescriptions, falls under Pharmaceuticals section B and E.

MexicoPrescription onlyGrupo III

Ley General de Salud³⁷

The Ley General de Salud lists alprazolam among the benzodiazepines in Article 245, fraction III. Article 251 provides that psychotropic substances in that group may be acquired only with a medical prescription, which may be dispensed up to three times within six months.

New ZealandPrescription onlySchedule 3 Part 5

Misuse of Drugs Act 1975³⁹

Alprazolam is listed in Part 5 of Schedule 3 to the Misuse of Drugs Act 1975 as a Class C controlled drug. It is therefore subject to New Zealand's controlled-drug regime, under which lawful medical supply is by prescription.

PolandPrescription onlyIV-P

Regulation of the Minister of Health on the list of psychotropic substances, narcotic drugs and new psychoactive substances⁴²⁴³

Alprazolam is listed as a psychotropic substance in group IV-P in the Polish ministerial schedule. It is subject to the controls governing psychotropic substances under the Act on Counteracting Drug Addiction.

RussiaSchedule III

Classified as a Schedule III controlled substance since 2013. Requires prescription for legal possession.

South AfricaPrescription onlySchedule 5

Medicines and Related Substances Act 101 of 1965: Schedules⁴⁹

Listed as a Schedule 5 substance, making it available by prescription only. Marketed under the brand name Zopax.

SpainPrescription onlyList IV

Real Decreto 2829/1977, Annex⁵³⁵⁴

Alprazolam is included in the Spanish psychotropic-substances regime established by Real Decreto 2829/1977. Its manufacture, distribution, prescription, and dispensing are subject to the controls applicable to listed psychotropic substances.

SwitzerlandVerzeichnis B

Specifically named as a controlled substance under Verzeichnis B of Swiss narcotics legislation. Available by prescription in 0.25, 0.5, 1, and 2 mg dose units.

United KingdomPrescription onlySchedule 4

Misuse of Drugs Regulations 2001⁵⁸

Classified as a Class C drug under the Misuse of Drugs Act 1971⁵⁹ and listed under Schedule 4, Part I (CD Benz POM) of the Misuse of Drugs Regulations 2001.⁶⁰ Requires a valid prescription for lawful possession. Not available through the National Health Service.

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Alprazolam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Alprazolam

8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Xanax, Xannies, Zannies, Bars, Xanbars

Psychoactive Class

Depressant Anxiolytic Sedative Muscle Relaxant GABAergic Anticonvulsant

Chemical Class

Benzodiazepine (triazolobenzodiazepine)

Dosage & Duration

Dosage

Threshold~0.25 mg

Light0.25-0.5 mg

Moderate0.5-1.5 mg

Strong1.5-2 mg

Heavy2+ mg

Bioavailability

84-91%

Duration

Onset20-40 minutes

Come Up60-120 minutes

Peak2-4 hours

Offset2-6 hours

After Effects6-24 hours

Total5-8 hours

Half-life

9-16 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of alprazolam can be broken down into several components which progressively intensify proportional to dosage.

Dizziness Muscle relaxation Physical euphoria Motor control loss Respiratory depression Seizure suppression

Cognitive

Amnesia Anxiety suppression Thought deceleration Disinhibition Information processing suppression Euphoria Compulsive redosing

Forked from Subjective Effect Documentation

by Josie KinsSeptember 2015.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AlcoholGHB/GBLOpioidsTramadol

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

DiphenhydraminePCP

Caution

Use caution

DXMKetamineMXE

TripSit

Tolerance

Full Tolerance

Cross Tolerance

Benzodiazepines (all members of the class)

Baseline Reset

Harm Potential

Addiction & Dependence

Psychological

High

Physical

Extremely High

Toxicity

Central Nervous System

Misuse of alprazolam has been shown to cause cognitive impairment including memory deficits; occasional use at therapeutic doses does not appear to cause lasting neurological damage.⁵

Vascular/Muscular

Respiratory

Respiratory depression can occur at high doses or in overdose, particularly when combined with other depressants; patients with pre-existing respiratory impairment are at increased risk.^?

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Development

Legality

International

UN Convention on Psychotropic Substances 1971: Schedule IV.

1961 Convention: not internationally scheduled.

1988 Convention: not internationally scheduled.

By Country

United StatesPrescription onlySchedule IV

21 CFR 1308.14⁶¹

AustraliaPrescription onlySchedule 8

Therapeutic Goods (Poisons Standard—February 2025) Instrument 2025¹³

BelgiumPrescription onlyAnnexe III

Arrêté royal du 6 septembre 2017 réglementant les substances stupéfiantes et psychotropes¹⁷¹⁸

Benzodiazepines including alprazolam are regulated as prescription medications under Belgian pharmaceutical law.

CanadaPrescription onlySchedule IV

Controlled Drugs and Substances Act²¹²²

Controlled under Schedule IV of the Controlled Drugs and Substances Act.²³ Requires a valid prescription for lawful possession.

Czech RepublicPrescription onlySeznam č. 7

Nařízení vlády č. 463/2013 Sb., o seznamech návykových látek²⁶²⁷

Controlled substance under Nařízení vlády č. 463/2013 Sb. Available exclusively with a standard prescription (without blue stripe designation).

FrancePrescription onlyListe I

Arrêté du 7 octobre 1991 fixant la liste des substances vénéneuses à propriétés hypnotiques et/ou anxiolytiques³¹

Classified as a List I substance under French pharmaceutical law. Available only by prescription and illegal to purchase without one.

IrelandPrescription onlySchedule 4

Misuse of Drugs (Amendment) Regulations 2022³³

Classified as a Schedule 4 controlled medicine. Requires a valid prescription for legal possession.

JapanPrescription onlyArticle 4(45)

Cabinet Order Designating Narcotics, Narcotic Raw Plants, Psychotropics, and Narcotics/Psychotropics Precursors³⁵³⁶

NetherlandsPrescription onlyLijst II

Opiumwet³⁸

Controlled under List 2 of the Opium Law. Available for legitimate medical use with a valid prescription.

PhilippinesPrescription onlySchedule 3

Philippine Schedules of Dangerous Drugs, Annex A⁴⁰⁴¹

PortugalPrescription onlyTable IV

Decree-Law No. 15/93, annexed tables⁴⁴⁴⁵

SingaporePrescription onlyFirst Schedule

Health Products (Therapeutic Products) Regulations 2016⁴⁶⁴⁷⁴⁸

South KoreaPrescription onlySchedule 6

Enforcement Decree of the Narcotics Control Act⁵⁰⁵¹⁵²

SwedenPrescription onlyFörteckning IV

Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika⁵⁵⁵⁶

Regulated as a prescription medication under List IV of the Narcotics Drugs Act (Narkotikastrafflagen) of 1968.

TurkeyGreen PrescriptionCitation needed

Designated as a 'green prescription' medication, indicating stricter prescribing controls. Possession or sale without prescription is illegal.

ArgentinaPrescription onlyLista IV

Resolution 518/1985, Annex I¹¹¹²

AustriaPrescription onlyNR

Rezeptpflichtverordnung¹⁵¹⁶

Legal for medical use under the Arzneimittelgesetz (AMG). Possession or sale without a valid prescription is prohibited under the Suchtmittelgesetz (SMG).

BrazilPrescription onlyLista B1

Portaria SVS/MS No. 344/1998¹⁹²⁰

Alprazolam is included in Lista B1 of Portaria SVS/MS No. 344/1998. Dispensing is subject to the Notificação de Receita B requirement for psychotropic substances under special control.

ChinaPrescription onlyCategory II

Catalogue of Medicinal Psychotropic Substances (2025 Edition)²⁴²⁵

DenmarkPrescription onlyList E (E003)

Executive Order no. 405 of 26 March 2026 on Euphoriant Substances²⁸²⁹³⁰

GermanyPrescription onlyAnlage III

Betäubungsmittelgesetz³²

ItalyPrescription onlyTabella IV

D.P.R. 9 ottobre 1990, n. 309³⁴

Listed in Tabella 4 under the Testo unico sulla droga (D.P.R. 309/90). For medical prescriptions, falls under Pharmaceuticals section B and E.

MexicoPrescription onlyGrupo III

Ley General de Salud³⁷

New ZealandPrescription onlySchedule 3 Part 5

Misuse of Drugs Act 1975³⁹

PolandPrescription onlyIV-P

Regulation of the Minister of Health on the list of psychotropic substances, narcotic drugs and new psychoactive substances⁴²⁴³

RussiaSchedule III

Classified as a Schedule III controlled substance since 2013. Requires prescription for legal possession.

South AfricaPrescription onlySchedule 5

Medicines and Related Substances Act 101 of 1965: Schedules⁴⁹

Listed as a Schedule 5 substance, making it available by prescription only. Marketed under the brand name Zopax.

SpainPrescription onlyList IV

Real Decreto 2829/1977, Annex⁵³⁵⁴

SwitzerlandVerzeichnis B

Specifically named as a controlled substance under Verzeichnis B of Swiss narcotics legislation. Available by prescription in 0.25, 0.5, 1, and 2 mg dose units.

United KingdomPrescription onlySchedule 4

Misuse of Drugs Regulations 2001⁵⁸

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Alprazolam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Alprazolam

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Development

Legality

International

By Country

References

Source Pages

Citations

Further Reading

Suggest an edit

Alprazolam

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

Psychosis Risk

Seizure Risk

History & Culture

Discovery and Development

Legality

International

By Country

References

Source Pages

Citations

Further Reading

Suggest an edit